Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension

Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension

Journal of Human Hypertension advance online publication, April 17 2014.
doi:10.1038/jhh.2014.27

Authors: C S Oxlund, C Cangemi, J E Henriksen, I A Jacobsen, J Gram, K Schousboe, L Tarnow, W S Argraves & L M Rasmussen

Source: Journal of Human Hypertension - April 17, 2014 Category: Cardiology Authors: C S OxlundC CangemiJ E HenriksenI A JacobsenJ GramK SchousboeL TarnowW S ArgravesL M Rasmussen Source Type: research